PAV-104

N/A

Report date: 2025/01/26 16:40:12
NME

Base Information

Drug NamePAV-104
Drug Alias NameSmall molecule therapeutic for COVID-19/Influenza/Common cold (Prosetta Biosciences)PAV-104
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVirus replication inhibitors
TargetsUpdating
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Influenza, HumanCommon Cold
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesProsetta Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesProsetta Biosciences Inc
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Influenza, HumanCommon Cold
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A